Patent Assignment
Reel/Frame 049586/0362
Assignment of Assignor's Interest
Recorded: 2019-06-26
Pages: 12
Assignor
MABVAX THERAPEUTICS, INC.
Executed: 2019-05-07
Assignee
BIONTECH RESEARCH AND DEVELOPMENT, INC.
AN DER GOLDGRUBE 12, MAINZ, 55131, GERMANY
Covered Properties
(7)
Nucleic Acids Encoding Human Antibodies To Sialyl-Lewis A
Nucleic Acids Encoding Human Antibodies To Sialyl-Lewis a
Application:
61/870,137 →
Human Monoclonal Antibodies to Ganglioside GD2
Human Monoclonal Antibodies to Ganglioside GD2
Application:
62/007,874 →
Human Monoclonal Antibodies to Ganglioside GD2
Nucleic Acids Encoding Human Antibodies to Sialyl-Lewis A
Human Monoclonal Antibodies to Ganglioside GD2
PCT:
PCT/US2015/033954 ↗
Related Assignments
(10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 18, 2014
From: SAWADA, RITSUKO; SUN, SHU-MAN; SCHOLZ, WOLFGANG
To: MABVAX THERAPEUTICS, INC.
Reel/Frame 032233/0750 →
Assignment of Assignor's Interest
Nov 13, 2014
From: SAWADA, RITSUKO; SUN, SHU-MAN; SCHOLZ, WOLFGANG
To: MABVAX THERAPEUTICS, INC.
Reel/Frame 034168/0480 →
Assignment of Assignor's Interest
Apr 15, 2015
From: SCHOLZ, WOLFGANG; SAWADA, RITSUKO
To: MABVAX THERAPEUTICS, INC.
Reel/Frame 035419/0343 →
Assignment of Assignor's Interest
Aug 10, 2015
From: SCHOLZ, WOLFGANG; SAWADA, RITSUKO
To: MABVAX THERAPEUTICS, INC.
Reel/Frame 036291/0269 →
Assignment of Assignor's Interest
Dec 15, 2015
From: SCHOLZ, WOLFGANG; SAWADA, RITSUKO
To: MABVAX THERAPEUTICS, INC.
Reel/Frame 037296/0710 →
Security Interest
Jul 12, 2018
From: MABVAX THERAPEUTICS HOLDINGS, INC.; MABVAX THERAPEUTICS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT AND AS A LENDER
Reel/Frame 046337/0252 →
Assignment of Assignor's Interest
Jun 21, 2019
From: SCHOLZ, WOLFGANG; SAWADA, RITSUKO
To: MABVAX THERAPEUTICS, INC.
Reel/Frame 049556/0114 →
Assignment of Assignor's Interest
Jun 21, 2019
From: SAWADA, RITSUKO; SUN, SHU-MAN; SCHOLZ, WOLFGANG
To: MABVAX THERAPEUTICS, INC.
Reel/Frame 049556/0001 →
Change of Address in Recorded Assignment
Jan 31, 2020
From: MABVAX THERAPEUTICS, INC.
To: BIONTECH RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 051762/0305 →
Assignment of Assignor's Interest
Sep 18, 2025
From: BIONTECH RESEARCH AND DEVELOPMENT, INC.
To: BIONTECH SE
Reel/Frame 072302/0591 →